| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.99B | +0.3% |
| Cost of Revenue | $1.62B | +0.4% |
| Gross Profit | $362.9M | -0.3% |
| R&D Expense | $23.6M | +2.6% |
| SG&A Expense | $228.7M | -2.2% |
| Operating Income | -$384.4M | -6201.6% |
| Pre-tax Income | -$463.0M | -486.8% |
| Income Tax | -$125.6M | -315.9% |
| Net Income | -$337.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.2M | -10.7% |
| Accounts Receivable | $180.9M | +11.4% |
| Inventory | $329.1M | -7.3% |
| Current Assets | $638.6M | -3.0% |
| Total Assets | $2.05B | -16.2% |
| Current Liabilities | $285.3M | +3.9% |
| Long-term Debt | $1.03B | -7.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $133.8M | +41.1% |
| Capital Expenditures | $40.0M | -27.3% |
| Investing Cash Flow | -$37.0M | +34.7% |
| Financing Cash Flow | -$106.7M | -90.9% |
| Free Cash Flow | $93.8M | +135.7% |
| -592.8% |
| EPS (Basic) | -$6.19 | -587.8% |
| EPS (Diluted) | -$6.19 | -587.8% |
| Total Liabilities |
| $1.55B |
| -2.3% |
| Stockholders' Equity | $498.7M | -41.9% |